Vanta Bioscience Financials Statement

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Mar-2023	Dec-2022	Mar-2022	Dec-2021	--
Gross Sales	3.45	2.82	4.31	--	--
Excise Duty	--	--	--	--	--
Net Sales	3.45	2.82	4.31	--	--
Other Operating Income	--	--	--	--	--
Other Income	0.68	0.01	0.40	--	--
Total Income	4.13	2.83	4.71	--	--
Total Expenditure	5.30	3.37	2.33	--	--
PBIDT	(1.17)	(0.54)	2.38	--	--
Interest	3.40	2.48	1.20	--	--
PBDT	(4.57)	(3.02)	1.18	--	--
Depreciation	1.36	1.31	0.66	--	--
Minority Interest Before NP	(2.10)	(1.86)	0.38	(0.38)	--
Tax	--	--	0.04	0.38	--
Deferred Tax	0.09	0.09	0.03	--	--
Reported Profit After Tax	(3.92)	(2.56)	0.07	--	--
Minority Interest After NP	--	--	--	--	--
Net Profit after Minority Interest	(3.92)	(2.56)	0.07	--	--
Extra-ordinary Items	--	--	--	--	--
Adjusted Profit After Extra-ordinary item	(3.92)	(2.56)	0.07	--	--
EPS (Unit Curr.)	(6.21)	(4.06)	0.11	--	--
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	--	--	--	--	--
Equity	6.31	6.31	6.31	6.31	--
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	(33.91)	(19.15)	55.22	--	--
PBDTM(%)	(132.46)	(107.09)	27.38	--	--
PATM(%)	(113.62)	(90.78)	1.62	--	--

QuickLinks for Vanta Bioscience Ltd.